Cargando…
Inhibition and induction of CYP enzymes in humans: an update
The cytochrome P450 (CYP) enzyme family is the most important enzyme system catalyzing the phase 1 metabolism of pharmaceuticals and other xenobiotics such as herbal remedies and toxic compounds in the environment. The inhibition and induction of CYPs are major mechanisms causing pharmacokinetic dru...
Autores principales: | Hakkola, Jukka, Hukkanen, Janne, Turpeinen, Miia, Pelkonen, Olavi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603454/ https://www.ncbi.nlm.nih.gov/pubmed/33111191 http://dx.doi.org/10.1007/s00204-020-02936-7 |
Ejemplares similares
-
PXR and 4β-Hydroxycholesterol Axis and the Components of Metabolic Syndrome
por: Hukkanen, Janne, et al.
Publicado: (2020) -
Nuclear Receptor PXR in Drug-Induced Hypercholesterolemia
por: Karpale, Mikko, et al.
Publicado: (2022) -
Effects of Ospemifene on Drug Metabolism Mediated by Cytochrome P450 Enzymes in Humans in Vitro and in Vivo
por: Turpeinen, Miia, et al.
Publicado: (2013) -
Pregnane X Receptor‒4β‐Hydroxycholesterol Axis in the Regulation of Overweight‐ and Obesity‐Induced Hypertension
por: Rahunen, Roosa, et al.
Publicado: (2022) -
Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver
por: Klein, Kathrin, et al.
Publicado: (2010)